# SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation

> **NCT03230747** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 72 (actual)

## Conditions studied

- Mitral Regurgitation
- Mitral Disease

## Interventions

- **DEVICE:** Edwards SAPIEN M3 System

## Key facts

- **NCT ID:** NCT03230747
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-09-14
- **Primary completion:** 2021-06-16
- **Final completion:** 2027-08
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230747, "SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03230747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*